Title

Earning Preview: HUA HONG SEMI this quarter’s revenue is expected to increase by 18.29%, and institutional views are cautiously bullish

Abstract

HUA HONG SEMI will report results on March 26, 2026 post-Market, with consensus pointing to higher revenue and improving earnings momentum as investors watch margins, utilization, and near-term order visibility.

Market Forecast

Based on the company’s previous disclosures and the latest forecast inputs, HUA HONG SEMI’s current-quarter revenue is estimated at 660.77 million RMB, implying year-over-year growth of 18.29%, while adjusted EPS is projected at 0.02 RMB per share with a 59.15% year-over-year increase; EBIT is expected to be -12.15 million RMB, suggesting narrowing operating losses versus the prior year. Forecasts for gross profit margin and net profit margin were not provided in the latest forecast dataset and are therefore omitted.

The main business highlight centers on steady demand within the company’s core manufacturing and sales operations, with the outlook supported by stable customer pull-through and a more favorable product mix against last year’s trough levels. The most promising segment remains the company’s semiconductor manufacturing and sales business, which delivered 659.88 million RMB in revenue last quarter, up 22.39% year over year, and is expected to sustain high-teens growth this quarter.

Last Quarter Review

In the previous quarter, HUA HONG SEMI delivered 659.88 million RMB in revenue (up 22.39% year over year), a gross profit margin of 12.95%, net profit attributable to the parent company of 17.45 million RMB, a net profit margin of 2.65%, and adjusted EPS of 0.01 RMB (up 166.67% year over year). Quarter on quarter, net profit contracted by 32.15%, reflecting normal seasonality and continued cost absorption related to capacity and platform ramps.

A key financial highlight was the year-over-year acceleration in top-line growth into the low-20% range, confirming that revenue has inflected from last year’s softer base while EPS turned positive on better cost discipline. The company’s primary business—semiconductor manufacturing and sales—accounted for 659.88 million RMB in revenue with a 22.39% year-over-year increase, underscoring broad recovery in core customer orders and a healthier blend of applications versus the prior year.

Current Quarter Outlook (with major analytical insights)

Main business: core manufacturing and sales

The company’s primary business is guided to demonstrate resilient year-over-year expansion, with revenue estimated at 660.77 million RMB for the current quarter. The step-up versus last year is linked to steadier customer order patterns and a gradually improving mix in specialty platforms. Operationally, utilization is the central swing factor for both top-line conversion and gross profit capture, as even modest improvements in loading can have an outsized impact on margins due to fixed-cost absorption dynamics. Management’s discipline around wafer pricing, cost pass-through, and incremental efficiency gains remains pivotal to translating growth into margin stability.

The interplay of depreciation and factory overheads continues to shape near-term profitability. In the last reported quarter, gross margin stood at 12.95%, and the company’s path to expanding that level in coming quarters depends on further leveraging installed capacity and executing on process yield improvements. Customer product ramps are likely to support unit growth, but the quality of revenue—anchored in ASPs and platform mix—will determine how much falls through to the bottom line. Inventory normalization at key customers this year reduces the risk of erratic ordering patterns, providing a more predictable production cadence.

From a working-capital perspective, stable receivables management and gradual days-in-inventory normalization should support cash conversion, even as capital intensity remains an important watchpoint. The company’s ability to limit non-essential opex while continuing essential R&D will help preserve operating leverage. With EBIT forecast at -12.15 million RMB for the quarter, the bias is toward narrowing operating losses versus last year’s baseline, which aligns with the projected rise in EPS to 0.02 RMB.

Most promising business: higher-value specialty mix within manufacturing

Within the broader manufacturing and sales umbrella, the more promising layer is the higher-value specialty mix that emphasizes platforms with structurally better ASPs and more defensible pricing. The evidence from last quarter—a 22.39% year-over-year revenue increase to 659.88 million RMB—indicates that customers are re-engaging in orders tied to these platforms after last year’s digestion phase. The current-quarter forecast implies sustained high-teens growth, suggesting the momentum is continuing, aided by incremental product launches and a richer order book tied to specialty flows.

Execution priorities are clustered around yield stabilization and cycle-time improvements across core nodes. Each incremental yield gain reduces scrap and rework, improving gross profit per wafer. The near-term opportunity is to capture share-of-wallet from existing customers by offering upgraded variants that consolidate functionality at mature nodes, thereby improving the price-mix without pushing unit volumes beyond capacity constraints. On the cost side, further normalization of material inputs and logistics supports a favorable cost-of-goods trajectory, amplifying the margin effects of the richer mix.

Pricing discipline is the third lever. Where contracts allow for periodic price reviews, maintaining realized ASPs near list levels keeps gross margins anchored even in quarters with flat utilization. This strategy aligns with the company’s projected EPS uplift to 0.02 RMB from 0.01 RMB last quarter, demonstrating that small shifts in mix and pricing can create visible earnings delta. The biggest incremental upside this quarter would stem from a modest improvement in loading that compounds with the richer mix, while the key risk would be any temporary pause in orders from a handful of large accounts.

Key stock-price swing factors this quarter

The first swing factor is margin trajectory relative to the last reported 12.95% gross margin. Investors will look for signs that fixed-cost absorption is improving, either through utilization gains or better product mix, as both channels directly influence quarterly earnings. If gross margin expands by even a few hundred basis points, the impact on net margin can be material given the prior quarter’s 2.65% net margin baseline, and this would reinforce the forecasted EPS lift.

The second swing factor is the pace of operating expense growth and its relationship to EBIT. With current-quarter EBIT projected at -12.15 million RMB, a narrower loss versus last year’s level is already embedded in expectations. Delivering or exceeding this trajectory requires opex discipline, measured R&D progress across key platforms, and tight management of SG&A. Any incremental opex for customer qualifications or pre-production activities should be offset by productivity gains elsewhere to prevent EBIT slippage.

The third swing factor is order visibility into the next quarter. The last quarter’s revenue of 659.88 million RMB and the current estimate of 660.77 million RMB frame a stable baseline, but the slope of bookings and backlog conversion will set the tone for management’s commentary. A confident view on sequential revenue stabilization, even without aggressive growth, would likely support sentiment because it implies continued mix resilience and cost leverage. Conversely, a cautious tone on near-term bookings could weigh on shares, as it may introduce uncertainty around the sustainability of the EPS improvement to 0.02 RMB.

Analyst Opinions

Across the recent preview cycle, the majority of institutional views lean bullish to cautiously bullish, with a minority neutral-to-cautious. Analysts emphasizing the improving earnings trajectory point to the forecasted 18.29% year-over-year revenue growth this quarter and the projected doubling of EPS to 0.02 RMB, while acknowledging that EBIT remains slightly negative but on a narrowing path. The crux of the bullish case is that operating leverage should begin to reassert itself as utilization normalizes and mix tilts toward higher-value flows, supporting margin repair from the last reported 12.95% gross margin and 2.65% net margin.

Citing recent broker commentary, several well-known institutions highlight the configuration of near-term earnings drivers. One widely followed global bank underscores the balanced setup between mix and utilization, noting that even modest improvements in loading can translate into measurable gross-margin gains because of fixed-cost absorption, a dynamic consistent with the expected EPS inflection to 0.02 RMB. Another large brokerage flags the year-over-year revenue growth cadence—22.39% in the last quarter and an estimated 18.29% this quarter—as indicative of a sustained recovery, with a view that the company is positioned to preserve ASPs within its specialty platforms while gradually lifting yields.

The prevailing bullish analysis also points to the asymmetry at the bottom line. Because the company printed only 17.45 million RMB in net profit last quarter, even a small improvement in margins can create a comparatively large percentage swing in earnings and return metrics, particularly if opex growth remains contained. This narrative aligns with the projected narrowing of EBIT losses and provides a basis for constructive sentiment into March 26, 2026 post-Market. Analysts in this camp generally expect stable or slightly firmer utilization, continued focus on richer product mix, and steady cost management to support incremental quarter-on-quarter improvement, which if realized, could validate the forecasted EPS and help the shares re-rate on better earnings visibility.

In sum, the majority opinion skews positive on near-term execution. The thesis rests on the combination of high-teens year-over-year revenue growth to 660.77 million RMB, EPS recovery to 0.02 RMB on a better mix and tighter costs, and a credible path to margin repair despite the forecasted -12.15 million RMB EBIT. While skeptics remain watchful of operating leverage and order timing, the dominant institutional view anticipates that the company will deliver on its forecast trajectory and exit the quarter with improving earnings momentum.